기사 (249건) 리스트형 웹진형 타일형 Institutional investors sought Celltrion while individuals returned to Shinpoong Pharmaceutical Institutional investors sought Celltrion while individuals returned to Shinpoong Pharmaceutical Seegene, the only company to achieve KRW 1 trillion in annual sales among KOSDAQ pharmaceuticals components Seegene, the only company to achieve KRW 1 trillion in annual sales among KOSDAQ pharmaceuticals components Pharmaceutical exports surged in March, approaching $1.5 billion Pharmaceutical exports surged in March, approaching $1.5 billion Pharmaceutical manufacturing R&D expenses exceed KRW 2 trillion, KRW 200 million per researcher Pharmaceutical manufacturing R&D expenses exceed KRW 2 trillion, KRW 200 million per researcher Korean listed pharmaceutical companies increase entertainment costs, 12 of them exceed KRW 1 billion Korean listed pharmaceutical companies increase entertainment costs, 12 of them exceed KRW 1 billion Pharmaceutical products exports fluctuate following statistics Pharmaceutical products exports fluctuate following statistics Korea’s diagnostic reagents trade surplus closes to $1 billion in two months Korea’s diagnostic reagents trade surplus closes to $1 billion in two months NovartisㆍJanssen received the most patent-approval by the MFDS in February NovartisㆍJanssen received the most patent-approval by the MFDS in February New record of Korea’s pharmaceuticals retail sales has stopped, growth is close to 20% New record of Korea’s pharmaceuticals retail sales has stopped, growth is close to 20% 11 pharmaceutical stocks in the KOSPI market ranked in the top 100 for monthly share price growth in February 11 pharmaceutical stocks in the KOSPI market ranked in the top 100 for monthly share price growth in February Impact of Russia-Ukraine crisis on the Korean healthcare industry Impact of Russia-Ukraine crisis on the Korean healthcare industry Top pharmaceutical companies relieve the cost burden, while the SG&A expense ratio increases Top pharmaceutical companies relieve the cost burden, while the SG&A expense ratio increases 처음처음이전이전이전11121314151617181920다음다음다음끝끝
